Saturday, April 29, 2017
- 5:30pm-7:30pm
-
Low Dose Valganciclovir for CMV Prophylaxis in the First Year of Kidney Transplantation.
Poster Session A: Kidney Complications I • Hall D1
- 5:30pm-7:30pm
-
Low Incidence of Acute Rejection within the Six Months After Transplantation in HIV Recipients Treated with Raltegravir, the ANRS 153 Treve Trial.
Poster Session A: Viral Conundrums • Hall D1
- 5:30pm-7:30pm
-
Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate Risk Renal Transplants: A Single Center Experience.
Poster Session A: Viral Conundrums • Hall D1
- 5:30pm-7:30pm
-
Measles Screening and Vaccination in Solid Organ Transplant Recipients: Adherence to Infectious Disease Community of Practice (IDCOP) Recommendations.
Poster Session A: Viral Conundrums • Hall D1
- 5:30pm-7:30pm
-
Medicinal Herb Cordyceps Sinensis Promotes Long-Term Allograft Survival by Tipping the Balance Between CD4+FoxP3+ Tregs and CD8+ Tcm Cells.
Poster Session A: Immunosuppression • Hall D1
- 5:30pm-7:30pm
-
MicroRNAs Differentiate Between Antibody and T-Cell Mediated Renal Allograft Rejection.
- 5:30pm-7:30pm
-
Minor Degree of Persistent Microscopic Hematuria in Potential Living Kidney Donors Is Associated with Pathology.
- 5:30pm-7:30pm
-
Modulating Ischemia-Reperfusion Injuries with Pharmacological Agents: A Bench-to-Bedside Approach.
- «Previous Page
- 1
- …
- 16
- 17
- 18
- 19
- 20
- …
- 32
- Next Page»